MedPath

A Case Management Algorithm for Women Victims of Violence

Not Applicable
Recruiting
Conditions
Post-Traumatic Stress Disorder
Violence-Related Symptom
Interventions
Other: Vigitrauma
Registration Number
NCT04953273
Lead Sponsor
University Hospital, Lille
Brief Summary

A considerable body of research has demonstrated that women who are victims of interpersonal violence are at substantially elevated risk for the development of post-traumatic stress disorder (PTSD). In France, victims can request a medico-legal examination in a clinical forensic medicine unit. Although these units are also a place for initial psychological examination, women often don't attend future scheduled appointments. Decision-making algorithm using phone contact are effective in suicide prevention. Our aim is to assess the effectiveness of case management algorithm using early phone contact compared to a control group treated as usual on clinical outcome after consultation requested in a clinical forensic medicine unit by female victims of violence.

Method: Prospective, multicenter, open-label, randomized controlled clinical trial, for women victims of violence. Victims randomized in VIGITRAUMA group will be contacted by phone at 3 weeks after the consultation in a clinical forensic medicine unit, and a second phone call can be done. If the subject is not contacted after the second phone call, he will receive a postcard.

Control group will benefit from usual follow-up.

All the subjects included will be then evaluated at 3 months, 6 months and 1 year during a phone call.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
756
Inclusion Criteria
  • Women
  • 18 years and older
  • Consultation requested in a clinical forensic medicine unit after being victim of violence
  • The person was exposed to: death, threatened death, actual or threatened serious injury, or actual or threatened sexual violence (PTSD criterion A - DSM -5)
  • With social insurance
  • Consent to participate to the study
Exclusion Criteria
  • Do no consent to participate to the study
  • Intrafamilial or intimate partner violence
  • Do not speak french

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
VigitraumaVigitraumaContact by phone at 3 weeks after the consultation in a clinical forensic medicine unit, and a second phone call if necessary. If the subject is not contacted after the second phone call, he will receive a postcard.
Primary Outcome Measures
NameTimeMethod
Clinical Outcome12 months

Rate of patients with a Clinical Global Impression (CGI) severity scale \< 4

Secondary Outcome Measures
NameTimeMethod
Severity of somatic symptoms3 months, 6 months and 12 months

Physical Health Questionnaire (PHQ-15)

Severity of post-traumatic stress disorder symptoms3 months, 6 months and 12 months

Post-traumatic stress disorder Checklist Scale-5

Suicidal ideation intensity12 months

The Beck Scale for Suicide Ideation (SSI) The Scale for Suicide Ideation (SSI; Beck, et al., 1979) is a brief 21-item scale that assesses the person's current intensity of attitudes, plans, and behaviors to commit suicide.

Medical cost12 months

Nnumber of hospitalizations, consultations, and drugs consummation

Judicial outcome12 months

Number of days of temporary inability to work

Number of suicide attempters12 months

Suicide risk

General psychopathology3 months, 6 months and 12 months

French version of Mini International Neuropsychiatric Interview (DSM 5)

Trial Locations

Locations (8)

University Hospital, Amiens

πŸ‡«πŸ‡·

Amiens, France

General Hospital, Boulogne sur Mer

πŸ‡«πŸ‡·

Boulogne-sur-Mer, France

General Hospital, Creil

πŸ‡«πŸ‡·

Creil, France

University Hospital, Lille

πŸ‡«πŸ‡·

Lille, France

General Hospital, Saint-Quentin

πŸ‡«πŸ‡·

Saint-Quentin, France

General Hospital, Valenciennes

πŸ‡«πŸ‡·

Valenciennes, France

University Hospital, Rouen

πŸ‡«πŸ‡·

Rouen, France

University Hospital, Caen

πŸ‡«πŸ‡·

Caen, France

Β© Copyright 2025. All Rights Reserved by MedPath